切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2015, Vol. 04 ›› Issue (04) : 195 -198. doi: 10.3877/cma.j.issn.2095-3232.2015.04.001

所属专题: 文献

述评

肝移植在胆道系统疾病中的应用
杨扬1,(), 汪国营1, 冯啸1   
  1. 1. 510630 广州,中山大学附属第三医院肝脏外科 肝移植中心
  • 收稿日期:2015-05-15 出版日期:2015-08-10
  • 通信作者: 杨扬
  • 基金资助:
    国家科技重大专项(2012ZX10002016-023,2012ZX10002017-005); 广州市健康医疗协同创新重大专项(201400000001-3); 广州市科技计划项目(2014J4100183); 中央高校基本科研业务费专项资金(12ykpy43,12ykpy47)

Application of liver transplantation in biliary tract diseases

Yang Yang1(), Guoying Wang1, Xiao Feng1   

  • Received:2015-05-15 Published:2015-08-10
  • Corresponding author: Yang Yang
引用本文:

杨扬, 汪国营, 冯啸. 肝移植在胆道系统疾病中的应用[J]. 中华肝脏外科手术学电子杂志, 2015, 04(04): 195-198.

Yang Yang, Guoying Wang, Xiao Feng. Application of liver transplantation in biliary tract diseases[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2015, 04(04): 195-198.

[1]
Lai HS, Chen WJ, Chen CC, et al. Long-term prognosis and factors affecting biliary atresia from experience over a 25 year period[J]. Chang Gung Med J, 2006, 29(3): 234-239.
[2]
Bijl EJ, Bharwani KD, Houwen RH, et al. The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review[J]. Neth J Med, 2013, 71(4): 170-173.
[3]
Lee S, Park H, Moon SB, et al. Long-term results of biliary atresia in the era of liver transplantation[J]. Pediatr Surg Int, 2013, 29(12): 1297-1301.
[4]
Tiao MM, Yang CY, Tsai SS, et al. Liver transplantation for biliary atresia in Taiwan: a national study[J]. Transplant Proc, 2008, 40(10): 3569-3570.
[5]
Seda Neto J, Feier FH, Bierrenbach AL, et al. Impact of Kasai portoenterostomy on liver transplantation outcomes: a retrospective cohort study of 347 children with biliary atresia[J]. Liver Transpl, 2015, DOI: 10.1002/lt.24132[Epub ahead of print].
[6]
Wang Q, Yan L, Zhang M, et al. Can primary LDLT be the alternative first line treatment for infant patients with biliary atresia?[J]. Hepatogastroenterology, 2013, 60(124): 807-812.
[7]
Ogawa E, Hori T, Doi H, et al. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience[J]. Clin Transplant, 2014, 28(9): 1031-1040.
[8]
Poupon R. Evidence-based treatment of primary biliary cirrhosis[J]. Dig Dis, 2014, 32(5):626-630.
[9]
Reichen J. Review: ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary biliary cirrhosis[J]. ACP J Club, 2008, 148(1): 17.
[10]
Milkiewicz P. Liver transplantation in primary biliary cirrhosis[J]. Clin Liver Dis, 2008, 12(2): 461-472.
[11]
Carbone M, Neuberger J. Liver transplantation in PBC and PSC: indications and disease recurrence[J]. Clin Res Hepatol Gastroenterol, 2011, 35(6/7):446-454.
[12]
European Association for the Study of the Liver. Easl clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267.
[13]
Lammers WJ, van Buuren HR, Hirschfield GM, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study[J]. Gastroenterology, 2014, 147(6): 1338-1349, e5.
[14]
Silveira MG, Talwalkar JA, Lindor KD, et al. Recurrent primary biliary cirrhosis after liver transplantation[J]. Am J Transplant, 2010, 10(4): 720-726.
[15]
Montano-Loza AJ, Wasilenko S, Bintner J, et al. Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation[J]. Am J Transplant, 2010, 10(4): 852-858.
[16]
Pandanaboyana S, Bell R, Bartlett AJ, et al. Meta-analysis of duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis[J]. Transpl Int, 2015, 28(4):485-491.
[17]
Venkat VL, Ranganathan S, Mazariegos GV, et al. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients[J]. Liver Transpl, 2014, 20(6): 679-686.
[18]
Gelley F, Zádori G, Görög D, et al. Recurrence of primary sclerosing cholangitis after liver transplantation: the Hungarian experience[J]. Interv Med Appl Sci, 2014, 6(1): 16-18.
[19]
Maithel SK, Gamblin TC, Kamel I, et al. Multidisciplinary approaches to intrahepatic cholangiocarcinoma[J]. Cancer, 2013, 119(22): 3929-3942.
[20]
Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma[J]. Surgery, 2013, 153(6): 811-818.
[21]
Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? a review of 17 years of experience in a tertiary institution[J]. Surgery, 2015, 157(4): 666-675.
[22]
Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?[J]. Am J Transplant, 2014, 14(3): 660-667.
[23]
Hashimoto K, Miller CM. Liver transplantation for intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci, 2015, 22(2):138-143.
[24]
DeOliveira ML. Liver transplantation for cholangiocarcinoma: current best practice[J]. Curr Opin Organ Transplant, 2014, 19(3): 245-252.
[25]
Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers[J]. Gastroenterology, 2012, 143(1): 88-98, e3.
[26]
Duignan S, Maguire D, Ravichand CS, et al. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience[J]. HPB, 2014, 16(1):91-98.
[27]
Welling TH, Feng M, Wan S, et al. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma[J]. Liver Transpl, 2014, 20(1): 81-88.
[28]
Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma[J]. Curr Opin Gastroenterol, 2012, 28(3):244-252.
[29]
Chen ZY, Yan LN, Zeng Y, et al. Preliminary experience with indications for liver transplantation for hepatolithiasis[J]. Transplant Proc, 2008, 40(10): 3517-3522.
[30]
Zahmatkeshan M, Bahador A, Geramizade B, et al. Liver transplantation for caroli disease[J]. Int J Organ Transplant Med, 2012, 3(4): 189-191.
[31]
Harring TR, Nguyen NT, Liu H, et al. Caroli disease patients have excellent survival after liver transplant[J]. J Surg Res, 2012, 177(2): 365-372.
[32]
Mabrut JY, Kianmanesh R, Nuzzo G, et al. Surgical management of congenital intrahepatic bile duct dilatation, Caroli's disease and syndrome: long-term results of the French Association of Surgery multicenter study[J]. Ann Surg, 2013, 258(5): 713-721.
[1] . 肝移植治疗终末期肝病[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 1-.
[2] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 陆闻青, 陈昕怡, 任雪飞. 遗传代谢病儿童肝移植受者术后生活质量调查研究[J]. 中华移植杂志(电子版), 2023, 17(05): 287-292.
[5] 范铁艳, 李君, 陈虹. 肝移植术后新发戊型病毒性肝炎的诊治经验[J]. 中华移植杂志(电子版), 2023, 17(05): 293-296.
[6] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[7] 汤鹏昊, 张武. 肠道微生态与肝移植围手术期并发症相关研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 303-307.
[8] 祝丽娜, 杨子祯, 张迪, 张勇, 蔡金贞, 王建红. 超声造影在肝移植术后肝动脉并发症中的应用价值[J]. 中华移植杂志(电子版), 2023, 17(04): 240-245.
[9] 中国器官移植发展基金会器官移植受者健康管理专家委员会, 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 国家肝脏移植质控中心. 肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(04): 193-204.
[10] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[11] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[12] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[15] 王晓东, 汪恺, 葛昭, 丁忠祥, 徐骁. 计算机视觉技术在肝癌肝移植疗效提升中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 361-366.
阅读次数
全文


摘要